In mice with pancreatic tumours, the hydrogel vaccine combined with ablation therapy effectively promotes systematic amplification of cDC1/CD8+ T-cell antitumor immunity, inhibiting pancreatic cancer progression. The gene discussed is MPPE1; the disease is familial pancreatic carcinoma.